FDA.reportPublic FDA data

nilotinib 50 MG Oral Capsule

RxCUI
2002717
RxNorm name
nilotinib 50 MG Oral Capsule
Display name
nilotinib 50 MG Oral Capsule
Full name
nilotinib 50 MG Oral Capsule
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NilotinibNILOTINIBApotex Corp.8283672c-619f-fe60-3d25-040f95ac14402026-02-24Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2002717
TasignaNILOTINIBNovartis Pharmaceuticals Corporation6093952a-5248-45cb-ad17-33716a4111462025-12-16Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2002717
nilotinibNILOTINIBNovadoz Pharmaceuticals LLC13b46e09-62d2-4ce9-b3c0-deafcb1f18422025-11-20Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2002717
NilotinibNILOTINIBDr. Reddy's Laboratories Inc805cc504-60bb-7743-5ada-679eb3badc7f2025-10-24Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2002717

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6093952a-5248-45cb-ad17-33716a411146nilotinib 50 MG Oral Capsule [PSN] · nilotinib 50 MG Oral Capsule [SCD] · nilotinib (as nilotinib hydrochloride) 50 MG Oral Capsule [SY]342These highlights do not include all the information needed to use TASIGNA safely and effectively. See full prescribing information for TASIGNA. TASIGNA ® (nilotinib) capsules, for oral use Initial U.S. Approval: 200720251216
805cc504-60bb-7743-5ada-679eb3badc7fnilotinib 50 MG Oral Capsule [PSN] · nilotinib 50 MG Oral Capsule [SCD] · nilotinib (as nilotinib hydrochloride) 50 MG Oral Capsule [SY]39These highlights do not include all the information needed to use NILOTINIB CAPSULES safely and effectively. See full prescribing information for NILOTINIB CAPSULES . NILOTINIB capsules, for oral use Initial U.S. Approval: 200720251024
8283672c-619f-fe60-3d25-040f95ac1440nilotinib 50 MG Oral Capsule [PSN] · nilotinib 50 MG Oral Capsule [SCD] · nilotinib (as nilotinib hydrochloride) 50 MG Oral Capsule [SY]39These highlights do not include all the information needed to use NILOTINIB CAPSULES safely and effectively. See full prescribing information for NILOTINIB CAPSULES. NILOTINIB capsules, for oral use Initial U.S. Approval: 200720250918
13b46e09-62d2-4ce9-b3c0-deafcb1f1842nilotinib 50 MG Oral Capsule [PSN] · nilotinib 50 MG Oral Capsule [SCD] · nilotinib (as nilotinib hydrochloride) 50 MG Oral Capsule [SY]31These highlights do not include all the information needed to use NILOTINIB CAPSULES safely and effectively. See full prescribing information for NILOTINIB CAPSULES. NILOTINIB capsules, for oral use Initial U.S. Approval: 200720251120